- Home
- ECOR vs IPSC Comparison
ECOR vs IPSC Comparison
Compare ECOR & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- IPSC
- Stock Information
- Founded
- ECOR 2005
- IPSC 2019
- Country
- ECOR United States
- IPSC United States
- Employees
- ECOR N/A
- IPSC N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- ECOR Health Care
- IPSC Health Care
- Exchange
- ECOR Nasdaq
- IPSC Nasdaq
- Market Cap
- ECOR 50.1M
- IPSC 49.6M
- IPO Year
- ECOR 2018
- IPSC 2021
- Fundamental
- Price
- ECOR $6.11
- IPSC $0.56
- Analyst Decision
- ECOR Strong Buy
- IPSC Strong Buy
- Analyst Count
- ECOR 2
- IPSC 5
- Target Price
- ECOR $25.50
- IPSC $3.33
- AVG Volume (30 Days)
- ECOR 71.2K
- IPSC 1.1M
- Earning Date
- ECOR 08-06-2025
- IPSC 08-07-2025
- Dividend Yield
- ECOR N/A
- IPSC N/A
- EPS Growth
- ECOR N/A
- IPSC N/A
- EPS
- ECOR N/A
- IPSC N/A
- Revenue
- ECOR $26,458,000.00
- IPSC $114,898,000.00
- Revenue This Year
- ECOR $23.21
- IPSC $1,064.82
- Revenue Next Year
- ECOR $44.10
- IPSC N/A
- P/E Ratio
- ECOR N/A
- IPSC N/A
- Revenue Growth
- ECOR 41.54
- IPSC 8286.72
- 52 Week Low
- ECOR $4.47
- IPSC $0.34
- 52 Week High
- ECOR $19.49
- IPSC $3.29
- Technical
- Relative Strength Index (RSI)
- ECOR 62.63
- IPSC 47.48
- Support Level
- ECOR $5.13
- IPSC $0.52
- Resistance Level
- ECOR $5.69
- IPSC $0.57
- Average True Range (ATR)
- ECOR 0.42
- IPSC 0.03
- MACD
- ECOR 0.09
- IPSC -0.01
- Stochastic Oscillator
- ECOR 91.27
- IPSC 40.00
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.